No marker may be more important than the reduction of runoff pollution from streets and sewers throughout the basin.
It is concluded that the deficiency in expression of NR3A subunit of NMDA glutamate receptors detected by a peripheral marker may be a risk factor making individuals vulnerable for opioid addiction.
However, several studies have reported the presence of altered CFDNA in over 50% of cancer patients, suggesting that this marker may be common and amenable for a variety of clinical and epidemiological studies.
The SCM2-indel1 marker may be helpful for MAS in japonica backgrounds.
Because a particular cell type is involved in a certain response within the host, this suggests that the activation of an individual ER stress marker may be cell-type specific and related to cell function.
Some reports have suggested that the marker may be useful for predicting response to therapy [7], [9], [10], whereas another has questioned its utility [14].
The details of this marker may be quite different than what occurs in STDP, but our model again should not depend critically on those details.
The analyses suggest that combining multiple markers is the best choice for inferring species identifications as any one marker may be unsuitable in a given case.
In our study, because mtDNA markers information is difficult to interpret, a new marker may be desirable and nuclear ITS2 is clearly a very good candidate.
Given these findings, we concluded that the close association of CD127 expression on CD8+ T-cells with HIV viral load further suggested that this marker may be an immunological surrogate of HIV disease status.
In conclusion, our findings suggest that CD133 marker may be useful to indicate the differentiated/undifferentiated state of osteosarcoma tumours and this may lead to new approaches in order to design a more specific therapy and ameliorate prognosis.
